XML 92 R76.htm IDEA: XBRL DOCUMENT v3.26.1
SECURITIES AND OTHER INVESTMENTS OWNED AND SECURITIES SOLD NOT YET PURCHASED - Schedule of equity method investments (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Schedule of Equity Method Investments [Line Items]          
Deficit/Equity attributable to investee $ 142,169   $ 142,169   $ (171,533)
Revenues 239,117 $ 225,302 591,177 $ 411,365  
Loss from continuing operations 21,597 71,687 243,756 51,725  
Net income attributable to investees 20,549 139,471 233,822 129,496  
B&W          
Schedule of Equity Method Investments [Line Items]          
Current assets 491,272   491,272   479,733
Noncurrent assets 266,573   266,573   178,151
Current liabilities 494,519   494,519   400,985
Noncurrent liabilities 435,421   435,421   489,106
Revenues 214,414 181,194 327,831 247,470  
Cost of revenues 170,957 141,133 260,968 183,176  
Loss from continuing operations (79,622) (7,763) (96,313) (79,081)  
Net income attributable to investees (76,945) (21,989) (67,715) (85,010)  
B&W | Investee          
Schedule of Equity Method Investments [Line Items]          
Deficit/Equity attributable to investee (172,095)   (172,095)   (232,207)
Net income attributable to investees (76,945) (22,007) (67,715) (85,072)  
Other Equity Investments          
Schedule of Equity Method Investments [Line Items]          
Current assets 25,801   25,801   23,491
Noncurrent assets 149,585   149,585   140,981
Current liabilities 15,863   15,863   22,988
Noncurrent liabilities 81,680   81,680   66,509
Revenues 20,039 18,500 35,576 30,223  
Cost of revenues 2,847 2,003 6,003 4,797  
Other Equity Investments | Investee          
Schedule of Equity Method Investments [Line Items]          
Deficit/Equity attributable to investee 77,843   77,843   $ 74,975
Net income attributable to investees $ 1,391 $ 6,323 $ 3,698 $ 4,009